Asia Pacific Human Embryonic Stem Cells Market Size & Outlook
Asia Pacific human embryonic stem cells market, 2018-2030 (US$M)
Related Markets
Asia Pacific human embryonic stem cells market highlights
- The Asia Pacific human embryonic stem cells market generated a revenue of USD 234.5 million in 2023.
- The market is expected to grow at a CAGR of 15.2% from 2024 to 2030.
- In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
- Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 234.5 million |
| Market revenue in 2030 | USD 632.2 million |
| Growth rate | 15.2% (CAGR from 2023 to 2030) |
| Largest segment | Regenerative medicine |
| Fastest growing segment | Drug Discovery & Development |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regenerative Medicine, Drug Discovery & Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 16.4% of the global human embryonic stem cells market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 632.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Embryonic Stem Cells Market Scope
Human Embryonic Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific human embryonic stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.36% in 2023. Horizon Databook has segmented the Asia Pacific human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific human embryonic stem cells market is expected to witness the fastest growth among all the regions over the forecast period. This growth can be attributive to rapid development and adoption of stem cell research and its applications in medicine in technologically advanced country such as Japan.
Further, emerging economies with competitive nature such as China has led to rapid expansion of infrastructure and facilities for innovation and research in hESC in the region. Further, rising R&D investment by key players for development and application of human ESCs for research and regenerative medicine applications is anticipated to drive growth in the region.
Though increased social, ethical and legal concerns in almost all the other countries are expected to limit the market growth, increasing awareness and growing popularity amongst researchers about significance of hESC are expected to fuel revenue generation for this market in the coming years.
Reasons to subscribe to Asia Pacific human embryonic stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific human embryonic stem cells market databook
-
Our clientele includes a mix of human embryonic stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific human embryonic stem cells market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific human embryonic stem cells market size, by country, 2018-2030 (US$M)
Asia Pacific Human Embryonic Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
